AAP News Vol. 13 No. 6 June 1997, p. 18
© 1997 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peter, G.
Right arrow Articles by Halsey, N.
Right arrow Search for Related Content

 Previous Article  |  Next Article 

Evolving IPV, OPV strategy raises questions: ACIP liaisons offer insights on latest vaccine recommendations

Georges Peter M.D., FAAP and Neal Halsey M.D., FAAP

Our practice has decided to initiate the sequential IPV-OPV schedule for infants who are beginning their immunizations. However the recommendations do not address what to give infants who have already received one dose of OPV. Should they receive OPV or, since we are adopting the sequential schedule, IPV for the second dose?

In many circumstances, IPV and OPV are considered interchangeable and, hence either OPV or IPV is acceptable. Because the risk of vaccine-associated paralytic poliomyelitis (VAPP) from OPV is primarily from the first dose, and one dose of OPV already has been given, completion of the schedule with OPV, in this case, is preferred. In addition, a major consideration in the sequential schedule is that at least two doses of OPV are necessary to achieve optimal intestinal immunity.